Cowen Group logo

Cowen Group

North America, New York, United States, New York

Description

Cowen Group, now operating as Cowen Inc. and recently acquired by TD Bank Group in 2023, is a diversified financial services firm based in New York. While widely recognized for its investment banking, research, and sales & trading capabilities, the firm also maintained a significant direct investment presence through its asset management arm, Cowen Investment Management. This division managed various private equity and hedge fund strategies, catering to different market segments and investment horizons.

A prominent component of Cowen's direct investment strategy was Cowen Healthcare Investments. This dedicated platform focused on making growth equity investments in innovative healthcare companies. Their approach typically involved providing capital to later-stage private companies that had demonstrated product-market fit and were poised for significant expansion. This focus differentiated them from early-stage venture capital firms, as they sought to support companies with established operations and clear pathways to commercialization.

One notable example of their commitment to the healthcare sector was the closing of Cowen Healthcare Investments IV, which secured $360 million in commitments in 2021. This fund was specifically designed to deploy capital into promising growth-stage healthcare enterprises, reflecting Cowen's strategic emphasis on this resilient and evolving industry. Their investment activities included leading and participating in substantial funding rounds, such as their involvement in a $50 million Series C round for Locus Biosciences, a biotechnology company.

Given their focus on growth equity and the scale of their funds, Cowen Investment Management typically deployed significant capital per transaction. Their first checks generally ranged from approximately $10 million for substantial minority stakes to around $50 million for leading larger growth rounds. This positions them as a key player for companies seeking substantial capital infusions for scaling operations, market expansion, or strategic acquisitions, rather than initial seed or Series A funding.

Investor Profile

Cowen Group has backed more than 42 startups, with 0 new investments in the last 12 months alone. The firm has led 13 rounds, about 31% of its total and boasts 29 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States, Canada, Israel.
  • Strong thematic focus on Health Care, Biotechnology, Therapeutics.
  • Typical check size: $10M – $50M.

Stage Focus

  • Series C (21%)
  • Series B (19%)
  • Post Ipo Equity (19%)
  • Series Unknown (12%)
  • Post Ipo Debt (7%)
  • Private Equity (7%)
  • Series A (7%)
  • Series D (5%)
  • Convertible Note (2%)

Country Focus

  • United States (83%)
  • Canada (7%)
  • Israel (5%)
  • United Kingdom (2%)
  • China (2%)

Industry Focus

  • Health Care
  • Biotechnology
  • Therapeutics
  • Medical
  • Biopharma
  • Health Diagnostics
  • Information Technology
  • Software
  • Manufacturing
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cowen Group frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 2
CA
North America, Massachusetts, United States, Boston
Co-Investments: 4
Tavistock Life Sciences
North America, Florida, United States, Windermere
Co-Investments: 2
Third Rock Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
Casdin Capital
North America, New York, United States, New York
Co-Investments: 3
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Aju IB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Yeoksamdong
Co-Investments: 2
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
ORI Capital
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 2
BridgeBio
North America, California, United States, Palo Alto
Co-Investments: 2

Which angels does Cowen Group often collaborate with?

IM
North America, Connecticut, United States
Shared Deals: 1

What are some of recent deals done by Cowen Group?

PolySign

Oakland, California, United States

PolySign develops secure and scalable infrastructure for financial institutions to fully leverage their digital assets.

Asset ManagementCryptocurrencyFinTechPaymentsSecurity
Series CApr 13, 2022
Amount Raised: $53,000,000
Hum Capital

New York, New York, United States

Hum Capital is a funding platform connecting companies with the right capital for their growth.

Financial ServicesFinTechFunding PlatformSoftware
Series ANov 18, 2021
Amount Raised: $12,000,000
Digital Prime Technologies

New York, New York, United States

Digital Prime Technologies is a provider of customizable prime brokerage technology solutions for financial institutions.

CryptocurrencyFinancial ServicesLendingRisk Management
Series UnknownNov 18, 2021
AlphaSense

New York, New York, United States

AlphaSense is a intelligence platform that uses artificial intelligence allowing professionals to make critical decisions.

AnalyticsArtificial Intelligence (AI)Machine LearningMarket ResearchSaaSSearch Engine
Series CSep 30, 2021
Amount Raised: $180,000,000
quip

Brooklyn, New York, United States

Quip designs and delivers oral care products, advice, and services.

DentalE-CommerceHealth CareProduct Design
Series BAug 31, 2021
Amount Raised: $100,000,000
ecoATM

San Diego, California, United States

ecoATM is an e-waste recycling company. ecoATM kiosks evaluate and purchase used electronics from consumers for cash or store credit.

Consumer ElectronicsRecyclingWaste Management
Private EquityJun 14, 2021
Amount Raised: $75,000,000
PolySign

Oakland, California, United States

PolySign develops secure and scalable infrastructure for financial institutions to fully leverage their digital assets.

Asset ManagementCryptocurrencyFinTechPaymentsSecurity
Series BMay 13, 2021
Amount Raised: $58,486,197
Omega Therapeutics

Cambridge, Massachusetts, United States

Omega Therapeutics offers a proprietary epigenomic programming platform.

BiotechnologyHealth Care
Series CMar 30, 2021
Amount Raised: $126,000,000
Proterra

Burlingame, California, United States

Proterra develops battery-electric buses that help eliminate fossil fuel dependency and reduce costs.

AutomotiveBatteryEnergy StorageManufacturing
Convertible NoteOct 15, 2020
Amount Raised: $200,000,000
Kyber Data Science

New York, New York, United States

Kyber Data Science is focused on developing and selling proprietary datasets across a variety of sectors to institutional investors.

AnalyticsData Center
Series AAug 3, 2020
Amount Raised: $10,000,000